Nyrada
Menu
NYR:
Market Cap*:
Price Delay ~20min
Home
About Us
Company Overview
Board of Directors
Senior Management
Scientific Advisory Board
Corporate Governance
Programs
NYR-BI03
Myocardial Ischemia
Stroke
Traumatic Brain Injury
Investors
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
News & Insights
Presentations & Interviews
Media
Newsletters
Publications
Contact Us
Contact Us
Working at Nyrada
Email Alerts
Investors
Home
>
Investors
>
ASX Announcements
Investor Welcome
Company Fact Sheet
ASX Announcements
Financial Reports
Corporate Announcements
Investor Presentations
Share Price Information
Investors Glossary
Annual Reports
Analyst Reports
Annual General Meeting
Extraordinary General Meeting
Past General Meetings
ASX Announcements
Filter by Year:
2025
2024
2023
2022
2021
2020
20-Jul-2023
Nyrada Review of Operating Costs
26-Jun-2023
Cholesterol-Lowering Program Update
9-Jun-2023
Brain Injury Program Preclinical Development Update
26-May-2023
Cholesterol-Lowering Program Preclinical Studies Completed
26-Apr-2023
Quarterly Activities Report and Appendix 4C
11-Apr-2023
Cholesterol-Lowering Program Preclinical Development Update
24-Feb-2023
Nyrada Half Year Results FY2023
24-Feb-2023
Appendix 4D and Half Year Report to 31 December 2022
30-Jan-2023
Quarterly Activities Report and Appendix 4C
18-Jan-2023
Collaboration with Walter Reed and UNSW Extended to 2025
Previous
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
Next
